Oncozenge AB (ONCOZ) — Tangible Net Worth Ratio
Oncozenge AB (ONCOZ) has a Tangible Net Worth Ratio of 26.4% as of September 2025. This metric is calculated by deducting intangible assets (Skr6.85 Million) from net assets (Skr9.30 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ONCOZ net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Oncozenge AB Tangible Net Worth Ratio (2020–2024)
This chart shows how Oncozenge AB's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 26.4%, reflecting net assets of Skr9.30 Million with intangible assets of Skr6.85 Million SEK. See ONCOZ cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Oncozenge AB (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Oncozenge AB from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ONCOZ market cap.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 31.2% | Skr9.95 Million | Skr6.85 Million | Skr11.43 Million | ▼ -32.1 pp |
| 2023 | 63.3% | Skr18.64 Million | Skr6.85 Million | Skr20.34 Million | ▼ -16.6 pp |
| 2022 | 79.8% | Skr33.97 Million | Skr6.85 Million | Skr36.89 Million | ▲ +17.2 pp |
| 2021 | 62.6% | Skr80.32 Million | Skr30.02 Million | Skr85.23 Million | ▲ +37.9 pp |
| 2020 | 24.7% | Skr29.28 Million | Skr22.05 Million | Skr38.30 Million | — |